Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 25,000 shares at $12.41 ($310K) on 2024-02-29, disclosed to the SEC on 2024-03-04.
Scheduled sale ($310k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.41 | 24,900 | $309K | 99.6% |
| 2 | $13.00 | 100 | $1K | 0.4% |
| Total | $12.41 avg | 25,000 | $310K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |